US FDA approves Tonix Pharma's drug to manage pain related to chronic condition – Reuters

  1. US FDA approves Tonix Pharma’s drug to manage pain related to chronic condition  Reuters
  2. Tonix Pharmaceuticals Holding Second Quarter 2025 Earnings: Misses Expectations  Yahoo Finance
  3. With FDA nod, Tonix’s Tonmya becomes first new fibromyalgia treatment in more than 16 years  Fierce Pharma
  4. Anticipating TNX-102 SL’s Addition to the Fibromyalgia Toolkit, with Andrew Sharobeem, DO  HCPLive
  5. Tonix Pharmaceuticals stock halted ahead of FDA approval news  Investing.com

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *